_version_ 1827332463784886272
author Marina Gómez-Llobell
María Martínez García
Carlos Serra Smith
Daniel Gómez Costas
Gillen Oarbeascoa Royuela
Diego Carbonell
Javier Anguita Velasco
Ana María Pérez Corral
Marjorie Pion
Veronica Astrid Pérez-Fernández
Isabel Fernández García
Mariana Bastos Oreiro
Paula Fernández-Caldas González
Ignacio Gómez-Centurión
Ana Alarcón
Eva Catalá
Diego Conde
Jorge Gayoso
Pablo Olmos
Carolina Martínez Laperche
Jose García-Domínguez
Yolanda Fernández
Rebeca Bailen
MI Kwon
author_facet Marina Gómez-Llobell
María Martínez García
Carlos Serra Smith
Daniel Gómez Costas
Gillen Oarbeascoa Royuela
Diego Carbonell
Javier Anguita Velasco
Ana María Pérez Corral
Marjorie Pion
Veronica Astrid Pérez-Fernández
Isabel Fernández García
Mariana Bastos Oreiro
Paula Fernández-Caldas González
Ignacio Gómez-Centurión
Ana Alarcón
Eva Catalá
Diego Conde
Jorge Gayoso
Pablo Olmos
Carolina Martínez Laperche
Jose García-Domínguez
Yolanda Fernández
Rebeca Bailen
MI Kwon
author_sort Marina Gómez-Llobell
collection DOAJ
first_indexed 2024-03-07T17:00:20Z
format Article
id doaj.art-bdd88c7d68024b4c8cab12c8dc5eec9a
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:00:20Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-bdd88c7d68024b4c8cab12c8dc5eec9a2024-03-03T03:25:27ZengWileyHemaSphere2572-92412023-08-017e491588110.1097/01.HS9.0000972492.49158.81202308003-01297P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.Marina Gómez-Llobell0María Martínez García1Carlos Serra Smith2Daniel Gómez Costas3Gillen Oarbeascoa Royuela4Diego Carbonell5Javier Anguita Velasco6Ana María Pérez Corral7Marjorie Pion8Veronica Astrid Pérez-Fernández9Isabel Fernández García10Mariana Bastos Oreiro11Paula Fernández-Caldas González12Ignacio Gómez-Centurión13Ana Alarcón14Eva Catalá15Diego Conde16Jorge Gayoso17Pablo Olmos18Carolina Martínez Laperche19Jose García-Domínguez20Yolanda Fernández21Rebeca Bailen22MI Kwon231 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain2 Gregorio Marañón Health Research Institute, Madrid, Spain4 Gregorio Marañón General University Hospital, Neurology Department, Madrid, Spain5 Gregorio Marañón General University Hospital, Pharmacy Department, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain7 Gregorio Marañon Hospital, Immunology Department, madrid, Spain7 Gregorio Marañon Hospital, Immunology Department, madrid, Spain8 Gregorio Marañón Hospital, Nuclear Medicine Department, madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain2 Gregorio Marañón Health Research Institute, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain4 Gregorio Marañón General University Hospital, Neurology Department, Madrid, Spain4 Gregorio Marañón General University Hospital, Neurology Department, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spainhttp://journals.lww.com/10.1097/01.HS9.0000972492.49158.81
spellingShingle Marina Gómez-Llobell
María Martínez García
Carlos Serra Smith
Daniel Gómez Costas
Gillen Oarbeascoa Royuela
Diego Carbonell
Javier Anguita Velasco
Ana María Pérez Corral
Marjorie Pion
Veronica Astrid Pérez-Fernández
Isabel Fernández García
Mariana Bastos Oreiro
Paula Fernández-Caldas González
Ignacio Gómez-Centurión
Ana Alarcón
Eva Catalá
Diego Conde
Jorge Gayoso
Pablo Olmos
Carolina Martínez Laperche
Jose García-Domínguez
Yolanda Fernández
Rebeca Bailen
MI Kwon
P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
HemaSphere
title P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
title_full P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
title_fullStr P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
title_full_unstemmed P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
title_short P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
title_sort p1401 identification of biomarkers and risk factors for immune effector cell associated neurotoxicity syndrome icans in cd19 directed car t cell therapy a retrospective machine learning based analysis
url http://journals.lww.com/10.1097/01.HS9.0000972492.49158.81
work_keys_str_mv AT marinagomezllobell p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT mariamartinezgarcia p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT carlosserrasmith p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT danielgomezcostas p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT gillenoarbeascoaroyuela p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT diegocarbonell p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT javieranguitavelasco p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT anamariaperezcorral p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT marjoriepion p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT veronicaastridperezfernandez p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT isabelfernandezgarcia p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT marianabastosoreiro p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT paulafernandezcaldasgonzalez p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT ignaciogomezcenturion p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT anaalarcon p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT evacatala p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT diegoconde p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT jorgegayoso p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT pabloolmos p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT carolinamartinezlaperche p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT josegarciadominguez p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT yolandafernandez p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT rebecabailen p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis
AT mikwon p1401identificationofbiomarkersandriskfactorsforimmuneeffectorcellassociatedneurotoxicitysyndromeicansincd19directedcartcelltherapyaretrospectivemachinelearningbasedanalysis